Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-08 Purchase | 2026-09-11 09:04 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $12.47 | $1,247,190 | 4,502,193 (Indirect Direct) | View |
| 2026-09-08 Purchase | 2026-09-11 09:03 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $12.47 | $1,247,190 | 4,502,193 (Indirect Direct) | View |
| 2026-09-03 Purchase | 2026-09-10 06:19 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 100,000 | $11.78 | $1,178,280 | 4,402,193 (Indirect Direct) | View |
| 2026-08-31 Purchase | 2026-09-09 11:03 am | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 90,000 | $11.59 | $1,042,677 | 4,302,193 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-30 Option Award | 2026-10-01 8:12 pm | N/A N/A | Helus Pharma Inc. | HELP | Glavine Paul Chief Growth Officer | 248,000 | $0 | 4,750,191 (Direct) | View |
Ownership | 2026-09-09 11:00 am | N/A N/A | CYBIN INC. | CYBN | Glavine Paul Chief Growth Officer | 0 | $0 | 4,317,456 (Direct) | View |